Product Information
GALANTAMINE HBR 4 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.2940 per EA under NDC 24979072204. Its NADAC has been published 127 times since May 1, 2024.
FDA first approved this application on Feb 6, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
24979072204
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GALANTAMINE HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077604FDA Approved
2/6/2009
TE Code
AB
On Market Since
3/6/2024
Pharmacological Classes
Price Statistics
The NADAC for GALANTAMINE HBR 4 MG TABLET has been published 127 times since May 1, 2024, and over the history we have for it it has declined 18.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2940 per EA |
|---|---|
| All-time high | $0.3609 (May 15, 2024) |
| All-time low | $0.2164 (May 22, 2024) |
| 52-week high | $0.3421 |
| 52-week low | $0.2687 |
| Median price | $0.2928 |
| Average price | $0.2975 |
| Largest weekly change | +41.2% (Sep 18, 2024) |
| Weeks tracked | 127 |
| Tracking since | May 1, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
galantamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GALANTAMINE HBR 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GALANTAMINE HBR 4 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.2940 per EA (NDC 24979072204), effective Sep 30, 2026.
How has the price of GALANTAMINE HBR 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for GALANTAMINE HBR 4 MG TABLET has declined 18.5%. It has been tracked across 127 weekly CMS publications since May 1, 2024.
What are the highest and lowest recorded NADAC prices for GALANTAMINE HBR 4 MG TABLET?
Since May 1, 2024, the NADAC for GALANTAMINE HBR 4 MG TABLET has ranged from a low of $0.2164 (May 22, 2024) to a high of $0.3609 (May 15, 2024), with a median of $0.2928 per EA.
Are there cheaper alternatives to GALANTAMINE HBR 4 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GALANTAMINE HBR 4 MG TABLET, is $0.2720 per EA — about 7% below GALANTAMINE HBR 4 MG TABLET.
Who manufactures GALANTAMINE HBR 4 MG TABLET?
GALANTAMINE HBR 4 MG TABLET (NDC 24979072204) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.